Philip is HPB and gastrointestinal surgeon at Radboudumc, Nijmegen, the Netherlands. He was trained at the Academic Medical Center, University of Amsterdam. He was the 2014 fellow at the Royal North Shore Hospital, Sydney, specialized in HPB surgery.
Philip’s main focus is on the treatment of patients with gallstones, pancreatic cancer and peritoneal metastasis (HIPEC surgery).
In 2013 he initiated the multicenter randomized Secure trial to investigate the effectiveness of cholecystectomy in patients with symptomatic gallstones. He currently coordinates the work of several clinical PhD students who perform clinical studies in the fields of gallstones, gallbladder cancer, shared decision making, surgical practice variation and health care efficiency.
His research into gallbladder cancer encompasses aspects of both clinical and molecular research; it focusses on both molecular mechanisms behind the development of this rare type as well as the optimization of patient selection for surgery and the value of (neo) adjuvant systemic therapy in an attempt to translate results from basic science into clinical practice.
Philip de Reuver is a medical specialist and Philip is HPB and gastrointestinal surgeon at Radboudumc. His main focus is on the treatment of patients with gallstones, pancreatic cancer and peritoneal metastasis (HIPEC surgery).
Ideally, every procedure in clinical practice and public health should take place based on proof, instead of intuition or 'experience'. Our aim is to innovate and personalize healthcare and public health.